Pregled bibliografske jedinice broj: 1104989
The Immunohistochemical Pattern of Epithelial-Mesenchymal Transition Markers In Endometrial Carcinoma
The Immunohistochemical Pattern of Epithelial-Mesenchymal Transition Markers In Endometrial Carcinoma // Applied Immunohistochemistry & Molecular Morphology, 28 (2020), 5; 339-346 doi:10.1097/pai.0000000000000754 (podatak o recenziji nije dostupan, članak, ostalo)
CROSBI ID: 1104989 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The Immunohistochemical Pattern of
Epithelial-Mesenchymal Transition Markers In
Endometrial Carcinoma
Autori
Rubeša-Mihaljević, Roberta ; Babarović, Emina ; Vrdoljak-Mozetič, Danijela ; Štemberger- Papić, Snježana ; Klarić, Marko ; Krašević, Maja ; Jonjić, Nives
Izvornik
Applied Immunohistochemistry & Molecular Morphology (1541-2016) 28
(2020), 5;
339-346
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, ostalo
Ključne riječi
endometrial carcinoma, epithelial-mesenchymal transition, E-cadherin, N-cadherin, immunohistochemistry
Sažetak
The majority of endometrial carcinoma are diagnosed at an early stage and exhibit a favorable prognosis. However, 10% to 15% of ECs recur and the majority are type II tumors which are high-grade carcinomas. The epithelial-mesenchymal transition (EMT) has been considered as a fundamental step for the development of the invasive phenotype of cancer cells. During EMT, many of epithelial surface markers, primarily E-cadherin disappear, and mesenchymal markers including N-cadherin gain. This feature resides predominantly at the invasive front (IF) of the tumor. Therefore, we examined the immunohistochemical expression of E-cadherin and N-cadherin at the IF, in central areas of the tumor and lymphovascular space, in type I and type II endometrial carcinoma. The association of each protein with the clinicopathologic features was also evaluated. Our results confirmed a stronger E-cadherin immunostaining in type I tumors indicating that the loss of E-cadherin may be responsible for a more aggressive behavior of type II ECs. In both types, E-cadherin was strongly expressed in central areas and the reactivity decreased toward the IF. On contrary, N-cadherin was overexpressed at the IF confirming an inverse relationship between these markers. In addition, a decrease in E- cadherin expression was observed in cells within the lymphovascular space. Downregulation of E-cadherin was associated only with high-grade tumors while no correlations between both markers and other clinicopathologic features were found. Our results confirm that EMT occurs at the IF that represents a critical interface between the tumor and the host.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Ustanove:
Klinički bolnički centar Rijeka
Profili:
Snježana Štemberger-Papić
(autor)
Emina Babarović
(autor)
Maja Krašević
(autor)
Roberta Rubeša-Mihaljević
(autor)
Nives Jonjić
(autor)
Danijela Vrdoljak Mozetič
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE